Study of safety and immunogenicity of Measles vaccine (Rouvax®) administered by transcutaneous route (France)

Update Il y a 3 ans
Reference: ISRCTN88861431

Woman and Man

  • | Country :
  • France
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Not provided at time of registration


Inclusion criteria

  • Vaccine/immunisation

Links